Home › Medical Devices › Cardiovascular Devices
Cardiovascular Devices Market Research Reports & Consulting
Cardiology devices are medical devices intended to use for diagnosis, treatment and monitoring of cardiovascular system and diseases. Cardiology devices are generally segmented into Cardiac Monitoring and Cardiac Rhythm Management, Cardiac Surgery, Electrophysiology and Ablation Devices, and Interventional Cardiology and Peripheral Vascular devices. The market is posed to witness a high growth due to increasing aging population, increasing number of patient suffering from cardiac diseases, rising patient awareness levels, technological advancement and increasing demand for minimally invasive medical procedures. According to the World Health Organization, globally, the population of individuals aged 65 and above was 570 million in 2013 and this figure is estimated to reach 1.5 billion (16% of global population) by 2050. Owing to this, the incidence of cardiovascular diseases is expected to increase. For instance, in 2013, 42.2 million people (aged above 60 years) were estimated to have CVD; moreover, in the U.S., from the total number of deaths among people aged 75 years and above, 66% deaths were related to CVDs. Furthermore, CVD is the major cause of mortality worldwide, translating to around 30% of all deaths. According to World Health Organization (WHO) estimates, 17.3 million people across the globe died of CVD in 2008 and around 24 million are estimated to die by 2030.
Technological advancements in the cardiology devices segment is one of the key trend and growth factor. Bioabsorbable stents is also one of the emerging technology. Bioabsorable stents technology is expected to seize a significant market size in the coming years, as it is capable of reducing post-surgical risks associated with restenosis to a great extent. Similarly, Tohoku University, Japan in collaboration with Konica Minolta have created a magnetic sensor that works at room temperature and that’s capable of detecting the changes of magnetic field of a person’s heart. Magnetocardiography could be a common heart assessment modality with the use of this sensor in the future.
There is growing need for compact devices. Ambulatory ECG monitoring is becoming increasingly important in both home care and clinical settings to detect symptomatic signs in patients with uncommon events. Holter monitors being used for ECG monitoring limit patient mobility owing to the size of the instruments. Hence, there is a growing need for compact devices that do not restrict patient mobility while simultaneously providing data.
The Cardiac Monitoring devices segment is categorized into electrocardiogram (ECG) devices, event monitors, implantable loop recorders (ILR), and cardiac output monitoring (COM) devices. The CRM devices segment is categorized into defibrillators, pacemakers, and cardiac resynchronization therapy (CRT) devices. Growth of the Cardiac Monitoring and Cardiac Rhythm Management devices market is propelled by increasing incidences of cardiovascular diseases, technological advancements resulting in launch of products in the mobile cardiac telemetry segment, and emergence of private institutional nursing and home care.
Cardiac surgery devices segment can be categorized into on-pump CABG perfusion circuit devices, off-pump CABG devices, endoscopic vessel harvesting devices, anastomosis-assist devices, heart valves, percutaneous heart valve therapy (PHVT) devices, heart valve repair devices, and ventricular-assist devices. Electrophysiology and Ablation Device segment are categorized into Electrophysiology Diagnostic Catheters, and Electrophysiology Ablation Catheters.
Interventional Cardiology and peripheral vascular devices can be categorized into eight segments: angioplasty stents, catheters, angioplasty balloons, Endovascular Aneurysm Repair (EVAR) Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and accessories. Major factors driving the growth of this market include rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements. Moreover, emerging economies such as India and China present an array of opportunities for the growth of this market.
Marketsandmarkets tracks various cardiology procedures volume such as Percutaneous Transluminal Coronary Angioplasty (PTCA), Percutaneous Transluminal Angioplasty (PTA), Endovascular Aneurysm Repair (EVAR), volume of devices such as Guiding Catheters, Intravascular Ultrasound (IVUS) Catheters/Optical Coherence Tomography (OCT) Catheters, Permanent and Retrievable Inferior Vena Cava (IVC) Filters, Pediatric Interventional Cardiology procedure, measures cost of cardiology procedures and devices used. MarketsandMarkets also tracks number of catheterization laboratories across various geographies. MarketsandMarkets estimates and tracks the value market for each product category of cardiology devices, analyzes recent trends in cardiology device market, technology trends, tracks latest developments such as new product launches, merger and acquisitions, analyzes reimbursement scenario and so on.see less
Cardiology devices are medical devices intended to use for diagnosis, treatment and monitoring of cardiovascular system and diseases. Cardiology devices are generally segmented into Cardiac Monitoring and Cardiac Rhythm Management, Cardiac Surgery, Electrophysiology and ....see more
Interventional Cardiology & Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021
The interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%. On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. The drug-eluting stents segment is projected to witness the highest growth in this market due to increasing number of regulatory approvals and new product launches.
|December 2016||$ 5650|
ECG Cable and ECG Lead wires Market by Material (Thermoplastic Elastomer, TPU), Usability (Reusable, Disposable), ECG Leadwires by Machine Type (3 lead, 5 lead), Patient Care Setting (Long term care facilities, Home care) - Forecast to 2021
The ECG cable and ECG leadwires market is expected to witness significant growth in the coming years owing mainly to factors such as the rapidly increasing geriatric population, rising incidences of cardiovascular diseases and technological advancements. The global ECG cable and ECG leadwires market is projected to reach USD 1.75 Billion by 2021 from USD 1.32 Billion in 2016, at a CAGR of 5.7% from 2016 to 2021. However, factors such as high cost of the disposable cables and leadwires is limiting the growth of this market.
|November 2016||$ 5650|
Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospital, Prehospital, Public Access, Home) - Global Forecasts to 2021
The defibrillators market is expected to reach USD 14.21 Billion by 2021 from USD 10.01 Billion in 2016, at a CAGR of 7.3% between 2016 and 2021. The development of technologically advanced defibrillators, rapid growth in the aging population with high risk of target diseases, growing focus of public and private organizations and key market players toward public access defibrillation, and increasing number of training and awareness programs across the globe are the major factors driving the growth of the defibrillators market.
|September 2016||$ 5650|
Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020
The global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation holds a larger market share and is poised to grow at a CAGR of 14.5% during the forecast period.
|December 2015||$ 5650|
Angiography Devices Market by Technology (X-Ray, CT, MRA), Products (Angiography systems, Catheters, Guide-Wires, Balloons, Contrast Media, Accessories), Application (Diagnostic &Therapeutic) & End-Users - Global Forecast to 2019
The global angiography devices market is estimated to grow at a CAGR of 7.2% from 2014 to 2019. The growing demand of innovative digital flat-panel detectors, CT & MRA devices, launch of new products based on innovative technology, increasing aging population and prevalence of disease, and rising awareness about the benefits of early diagnosis and treatment of cardiovascular diseases are the major factors driving the growth of the angiography devices market.
|January 2015||$ 5650|
Diagnostic Electrocardiograph (ECG) Market by Product (Resting, Stress, Holter Monitor), End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, Nursing Homes) & by Lead Type (Single, 3-6, 12) - Global Forecast to 2020
The global diagnostic ECG market is estimated to reach $4,875 million by 2018 at a high CAGR during the forecast period. The factors driving this market include the increasing geriatric population, rising incidences of lifestyle diseases, technological advancements in diagnostic ECG devices, and high growth rate in developing countries.
|June 2014||$ 5650|
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018
The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions.
|March 2014||$ 5650|